BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 22430995)

  • 1. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of antibiotics in intensive care units in Latin America: an observational study.
    Curcio D; Alí A; Duarte A; Defilippi Pauta A; Ibáñez-Guzmán C; Chung Sang M; Valencia E; Plano F; Paredes Oña F; Arancibia F; Montufar Andrade F; Morales Alava F; Cañarte Bermudez G; La Fuente Zerain G; Alanis Mirones V; Rojas Suarez J; Guzmán Torrico J; Silva J; Vergara Centeno J; Medina JC; Marín K; Caero LA; Durán Crespo L; Gómez Duque M; Játiva M; Belloni R; Romero R; Aguilera Perrogón R; Camacho Alarcón R; Camargo R; Cevallos S; Intriago Cedeño V; Urbina Contreras Z;
    J Chemother; 2009 Nov; 21(5):527-34. PubMed ID: 19933044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
    Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
    Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey.
    Erbay A; Bodur H; Akinci E; Colpan A
    J Hosp Infect; 2005 Jan; 59(1):53-61. PubMed ID: 15571854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
    Muller A; Bertrand X; Rogues AM; Péfau M; Alfandari S; Gauzit R; Dumartin C; Gbaguidi-Haore H;
    Antimicrob Resist Infect Control; 2018; 7():11. PubMed ID: 29387345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
    Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
    Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.